Cargando…

Remission of chronic actinic dermatitis on baricitinib: A case report

Chronic actinic dermatitis (CAD) is an immune‐mediated photodermatosis characterised by eczematous, pruritic changes to sun‐exposed skin. The pathophysiology of CAD is poorly understood, with current explanations including a hypersensitivity reaction and cross‐reactivity to contact allergens. The di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maguire, Jessica, Gleeson, David, Corso, Roberto, Pink, Andrew, Smith, Catherine, Ferguson, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690658/ https://www.ncbi.nlm.nih.gov/pubmed/38047267 http://dx.doi.org/10.1002/ski2.243

Ejemplares similares

A case report of therapeutically challenging chronic actinic dermatitis
por: Verma, Luvneet, et al.
Publicado: (2019)

Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2022)

Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience
por: ROGNER, Danielle, et al.
Publicado: (2022)

Correction to: Baricitinib: A Review in Moderate to Severe Atopic Dermatitis
por: Hoy, Sheridan M.
Publicado: (2022)

Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis
por: Vesely, Matthew D., et al.
Publicado: (2016)

Successful Treatment of Chronic Actinic Dermatitis with Dupilumab: A Case Report and Review of the Literature
por: Chen, Jiaoquan, et al.
Publicado: (2021)

Baricitinib: Various toxicities: 7 case reports
Publicado: (2021)

Baricitinib/cisatracurium besilate: Rhabdomyolysis: case report
Publicado: (2021)

Baricitinib: Various toxicities: 7 case reports
Publicado: (2022)

Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib
por: Nogueira, Miguel, et al.
Publicado: (2021)

Baricitinib Lipid-Based Nanosystems as a Topical Alternative for Atopic Dermatitis Treatment
por: Garrós, Núria, et al.
Publicado: (2023)

Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis
por: de Bruin-Weller, Marjolein S., et al.
Publicado: (2022)

The Effectiveness and Safety of Dupilumab for the Treatment of Recalcitrant Chronic Actinic Dermatitis: A Case Series
por: Chen, Jiaoquan, et al.
Publicado: (2023)

Mycosis Fungoides with Photosensitivity Mimicking Chronic Actinic Dermatitis
por: Sinha, Anwita, et al.
Publicado: (2020)

Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy
por: Peterson, Danielle M., et al.
Publicado: (2021)

Treatment of severe alopecia areata with baricitinib
por: Olamiju, Brianna, et al.
Publicado: (2019)

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib
por: Nezamololama, Novin, et al.
Publicado: (2020)

Baricitinib treatment of severe chronic hand eczema: Two case reports
por: Rosenberg, Fieke M., et al.
Publicado: (2022)

Remission of alopecia universalis in a patient with atopic dermatitis treated with dupilumab
por: Smogorzewski, Jan, et al.
Publicado: (2019)

Baricitinib: Disseminated intravascular coagulation and Escherichia coli infection: case report
Publicado: (2021)

Baricitinib/propofol: Pancreatitis following off-label use: case report
Publicado: (2022)

Chronic actinic dermatitis: An only presenting manifestation of human immunodeficiency virus in a young Indian male
por: Pawar, Manoj, et al.
Publicado: (2020)

Baricitinib exposure during pregnancy in rheumatoid arthritis
por: Costanzo, Giulia, et al.
Publicado: (2020)

Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult Patients
por: Radi, Giulia, et al.
Publicado: (2021)

Baricitinib/lopinavir/ritonavir: Elevated transaminases and off-label use: case report
Publicado: (2020)

Baricitinib/ceftriaxone/metoclopramide: Extrapyramidal syndrome and off label use: case report
Publicado: (2021)

Application of Baricitinib in Dermatology
por: Zhang, Jingya, et al.
Publicado: (2022)

Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies
por: Buhl, Timo, et al.
Publicado: (2021)

Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate‐to‐severe atopic dermatitis: A network meta‐analysis
por: Wan, Huiying, et al.
Publicado: (2022)

Pooled Analysis of Baricitinib Tolerability in Patients With Atopic Dermatitis in Relation to Acne, Headache, and Gastrointestinal Events From 8 Clinical Trials
por: Wollenberg, Andreas, et al.
Publicado: (2023)

Baricitinib/hydroxychloroquine: Various toxicities secondary to off-label use: 4 case reports
Publicado: (2021)

Baricitinib in severe and refractory peripheral ulcerative keratitis: a case report and literature review
por: Calvo-Río, Vanesa, et al.
Publicado: (2022)

Difficult-to-treat rheumatoid arthritis treated with Abatacept combined with Baricitinib: A case report
por: Qi, Jia-Ping, et al.
Publicado: (2023)

Clinical and immunological study of Tofacitinib and Baricitinib in refractory Blau syndrome: case report and literature review
por: Álvarez-Reguera, Carmen, et al.
Publicado: (2022)

Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials
por: King, Brett, et al.
Publicado: (2021)

Baricitinib for COVID-19: a suitable treatment?
por: Favalli, Ennio G, et al.
Publicado: (2020)

KIR Allelic Variation and the Remission of Atopic Dermatitis Over Time
por: Margolis, David J., et al.
Publicado: (2023)

Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab
por: Buttgereit, Thomas, et al.
Publicado: (2021)

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial
por: Reich, Kristian, et al.
Publicado: (2020)

Profile of Baricitinib and Its Potential in the Treatment of Moderate to Severe Atopic Dermatitis: A Short Review on the Emerging Clinical Evidence
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r5s1dmdtjg6lkvrvakga9gbt2o